FRIDAY, NOVEMBER 24, 2017

Red Cross warns of lack of vaccination funding

The Red Cross published a report this week that claims a $4 billion funding shortfall could threaten vaccination campaigns that prevent the deaths of over a million children every year. Read More »

Inovio awarded funding by the PATH Malaria Vaccine Initiative

Officials with Inovio Pharmaceuticals, Inc., recently announced that the PATH Malaria Vaccine Initiative has agreed to provide additional funding for the development of a malaria DNA vaccine candidate in non-human primates. Read More »

BARDA awards contract for stable influenza vaccine formulations

PATH, a Seattle-Based medical nonprofit group, has been awarded a $5.2 million Biomedical Advanced Research and Development Authority contract to develop stable formulations of both live and subunit influenza vaccines. Read More »

CDC reports vaccination rates remain high

Officials with the U.S. Centers for Disease Control and Prevention announced this week that coverage levels for most of the older vaccines for small children stayed high last year. Read More »

Researchers say influenza may be becoming Tamiflu-resistant

A research team in Singapore has found that influenza may be becoming resistant to the Tamiflu vaccine. Read More »

LigoCyte begins clinical trials for norovirus candidate

LigoCyte Pharmaceuticals announced on September 16 that it has begun clinical trials for a bivalent intramuscular norovirus vaccine candidate. Read More »

NanoBio announces positive data for next-generation flu vaccine

NanoBio, a spin-off from the University of Michigan, recently passed a major milestone when it announced initial positive data from an early-stage human clinical trial of its next-generation influenza vaccine. Read More »

Dengue infections on the rise in Asia

The World Health Organization has issued warnings over the growing number of severe cases and hospitalizations from dengue fever seen in much of Asia. Read More »

Drug-resistant bacteria found in more than 35 states

Drug-resistant bacteria have been found in more than 35 states and in an increasing number of countries. Read More »

Human trial of plant-produced flu vaccine launched

Officials with Fraunhofer USA Center for Molecular Biotechnology recently announced the launch of the first human trial of a plant-produced H1N1 influenza vaccine. Read More »

N.Y. pushing for mandatory health care worker flu vaccinations

Legislators in New York are attempting to revive a controversial measure that would call for mandatory flu vaccinations for health care workers. Read More »

New Delhi reports 72 new dengue fever cases

Seventy-two more cases of dengue fever were reported in New Delhi on September 19, bringing the total to 2,296 so far this year. Read More »

Illinois reports eight human West Nile virus cases this year

Despite cooler temperatures, the Illinois Department of Public Health has recently warned that the threat of West Nile Virus is not over, reporting that there have been eight human cases of the disease this year. Read More »

Second dengue fever infection found in France

Health officials in France have found a second case of dengue fever following a Sept. 13 infection that was the first recorded in the nation since 1928. Read More »

Flu vaccine may reduce risk of heart attack

Researchers at the University of Lincoln in England have announced that it is possible that an influenza vaccine reduced the risk of heart attack by 19 percent in British baby boomers age 40 and older. Read More »

Lowered heart attack risk-flu vaccination link called into question

A British study that suggested flu vaccinations reduced the risk of heart attacks in people over the age of 40 has been called into question by researchers who have studied the benefits of flu immunization. Read More »

Inovio begins testing new HIV vaccine

Inovio Pharmaceuticals has announced that it began the testing of a new vaccine for use against HIV on September 20. Read More »

Gulls may be transporting antibiotic-resistant bacteria

Researchers in Portugal fear that migratory birds may be spreading infections after it was discovered that seagulls can carry an antibiotic-resistant bacteria. Read More »

Second phase of TB vaccine clinical trials set

Officials with the Dutch biopharmaceutical company Crucell N.V. and the Areas Global TB Vaccine Foundation announced this week they will begin the second phase of clinical trials for a jointly-developed tuberculosis vaccine candidate. Read More »

Malaria might have come from gorillas, report says

New research suggests that human beings picked up the malaria parasite, Plasmodium falciparum, from the western gorilla, and not the previously suspected chimpanzee. Read More »